MYOD1 and colorectal carcinoma: Taken together our findings lends support to the hypothesis that promoter methylation of MYOD-1 may be an early biomarker of CRC risk since we have shown positive association with ageing and increasing WHR, both of which are established risk factors for developing colon cancer [18].